Minerva Neurosciences

5 FDA Decisions to Watch in Q1
BioSpace
Tue, 01/2/24 - 11:24 am
FDA
Iovance Biotherapeutics
melanoma
lifileucel
Minerva Neurosciences
schizophrenia
roluperidone
Viatris
Mapi Pharma
MS
multiple sclerosis
GA Depot
Madrigal Pharmaceuticals
NASH
resmetirom
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
beta thalassemia
Minerva Shares Plunge After FDA Rejects Schizophrenia Drug Candidate
BioSpace
Tue, 10/18/22 - 11:00 am
Minerva Neurosciences
schizophrenia
FDA
roluperidone
Minerva stumbles with U.S. application for schizophrenia med; shares down 15%
Seeking Alpha
Tue, 12/1/20 - 11:10 am
Minerva Neurosciences
schizophrenia
FDA
roluperidone
Minerva shares jump as J&J hands over $30M, revises insomnia drug pact; Iroko lays off 122
Endpoints
Sat, 06/3/17 - 09:17 am
Minerva Neurosciences
MIN-202
JNJ
Actelion
insomnia
Iroko Pharmaceuticals
Minerva's schizophrenia drug heads to late stages
BioPharma Dive
Tue, 05/16/17 - 10:31 pm
Minerva Neurosciences
MIN-101
schizophrenia
8 Speculative Biotech and Biohealth Stocks With Major Analyst Upside Calls
24/7 Wall St
Mon, 05/30/16 - 10:05 am
GW Pharma
Integra LifeSciences
Minerva Neurosciences
Neurocrine Biosciences
Teladoc
TG Therapeutics
Asterias
Innocoll GmbH
IPO Preview: Minerva Neurosciences
Seeking Alpha
Thu, 06/26/14 - 09:38 am
Minerva Neurosciences
IPOs
CNS